Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:10
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [21] Local Recurrence following Radiological Complete Response in Patients Treated with Subsegmental Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Gwon, Dong Il
    Kim, Gun Ha
    Chu, Hee Ho
    Kim, Jin Hyoung
    Ko, Gi-Young
    Yoon, Hyun-Ki
    CANCERS, 2023, 15 (20)
  • [22] Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization: Observation on CT during arterial portography
    Miyayama, Shiro
    Matsui, Osamu
    Zen, Yoh
    Yamashiro, Masashi
    Hattori, Yuki
    Orito, Nobuaki
    Matsui, Ken
    Tsuji, Kazunobu
    Yoshida, Miki
    Sudo, Yoshiko
    HEPATOLOGY RESEARCH, 2011, 41 (09) : 853 - 866
  • [23] Four-dimensional flow MR imaging for evaluating treatment response after transcatheter arterial chemoembolization in cirrhotic patients with hepatocellular carcinoma
    Moon, Chung Man
    Lee, Yun Young
    Kim, Seul Kee
    Jeong, Yong Yeon
    Heo, Suk Hee
    Shin, Sang Soo
    RADIOLOGIA MEDICA, 2023, 128 (10): : 1163 - 1173
  • [24] The value of dynamic subtraction MRI technique in the assessment of treatment response of hepatocellular carcinoma to transcatheter arterial chemoembolization
    Metwally, Lamiaa I. A.
    Mahmoud, Bahaa Eldin
    Yehia, Mahmoud
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2019, 50 (01)
  • [25] Imaging Hepatocellular Carcinoma with Dynamic CT Before and After Transarterial Chemoembolization: Optimal Scan Timing of Arterial Phase
    Saake, Marc
    Lell, Michael M.
    Eller, Achim
    Wuest, Wolfgang
    Heinz, Marco
    Uder, Michael
    Schmid, Axel
    ACADEMIC RADIOLOGY, 2015, 22 (12) : 1516 - 1521
  • [26] Combination of transcatheter arterial chemoembolization and CT-guided percutaneous segment ablation for hepatocellular carcinoma therapy A retrospective study
    Li, Wei
    Wang, Yang
    Gao, Wenfeng
    Zheng, Jiasheng
    MEDICINE, 2016, 95 (47)
  • [27] Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma
    Li, Sheng
    Zhang, Liang
    Huang, Zhi-Mei
    Wu, Pei-Hong
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [28] Reactivation of tuberculosis in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A report of 3 cases
    Kim, Yun Jeung
    Goh, Pyung Gohn
    Moon, Hee Seok
    Lee, Eaum Seok
    Kim, Seok Hyun
    Lee, Byung Seok
    Lee, Heon Young
    WORLD JOURNAL OF RADIOLOGY, 2012, 4 (05): : 236 - 240
  • [29] β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization
    Xu, Xiangxian
    Gao, Dazhi
    Yuan, Xiaoli
    Liu, Li
    Zhang, Xiang
    Liang, Xianxian
    Chen, Sui
    Ai, Min
    Chen, Bo
    Shi, Donghong
    Yang, Zhijian
    Hoffman, Robert M.
    Xu, Jian
    ANTICANCER RESEARCH, 2019, 39 (03) : 1129 - 1134
  • [30] Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization
    Drewes, Ralph
    Heinze, Constanze
    Pech, Maciej
    Powerski, Maciej
    Woidacki, Katja
    Wienke, Andreas
    Surov, Alexey
    Omari, Jazan
    DIGESTIVE DISEASES, 2022, 40 (05) : 596 - 606